Literature DB >> 9152646

Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group.

B Lindahl1, B Andrén, J Ohlsson, P Venge, L Wallentin.   

Abstract

In 963 patients, participating in a randomized study of low molecular weight heparin in unstable coronary artery disease and followed for 5 months, troponin T was determined. In the 766 patients with a pre-discharge exercise test both troponin T level and exercise test response were independent predictors of prognosis. Cardiac death or myocardial infarction occurred in 5, 9 and 13% of the patients with a maximal troponin T level of < 0.06 (n = 154), 0.06-0.2 (n = 175) and > or = 0.2 microgram.l-1 (n = 437), respectively. Based on exercise tolerance and occurrence of ST depression, patients with a low (n = 361), intermediate (n = 325) and high risk (n = 80) exercise test response were identified. In these, death or myocardial infarction occurred in 5, 13 and 29%, respectively. The combination of troponin T and the exercise test response allowed an even better categorization into low (n = 84), intermediate (n = 406) and high (n = 276) risk groups with 1, 7 and 20% death or myocardial infarction, respectively. Among those 197 patients unable to perform an exercise test the incidence was 3, 16 and 27% in patients with troponin T < 0.06, 0.06-0.2 and > or = 0.2 microgram.l-1, respectively. Thus, troponin T determinations and pre-discharge exercise tests alone and combined are valuable for risk assessment in unstable coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9152646     DOI: 10.1093/oxfordjournals.eurheartj.a015341

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  11 in total

1.  Cardiac troponins in chest pain can help in risk stratification.

Authors:  G S Hillis; K A Fox
Journal:  BMJ       Date:  1999-12-04

Review 2.  Guideline for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation. British Cardiac Society Guidelines and Medical Practice Committee and Royal College of Physicians Clinical Effectiveness and Evaluation Unit.

Authors: 
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

3.  Cumulative risk assessment in unstable angina: clinical, electrocardiographic, autonomic, and biochemical markers.

Authors:  S Kennon; C P Price; P G Mills; P K MacCallum; J Cooper; J Hooper; H Clarke; A D Timmis
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

Review 4.  Critical review of unstable angina and non-ST elevation myocardial infarction.

Authors:  P J Sheridan; D C Crossman
Journal:  Postgrad Med J       Date:  2002-12       Impact factor: 2.401

Review 5.  Recent advances in the management of unstable angina and non-Q-wave myocardial infarction.

Authors:  R P Steeds; K S Channer
Journal:  Br J Clin Pharmacol       Date:  1998-10       Impact factor: 4.335

6.  Early diagnosis of myocardial infarction: why measure cardiac enzymes?

Authors:  P O Collinson
Journal:  J Clin Pathol       Date:  1998-01       Impact factor: 3.411

Review 7.  Management strategies for a better outcome in unstable coronary artery disease.

Authors:  R W Campbell; L Wallentin; F W Verheugt; A G Turpie; A Maseri; W Klein; J G Cleland; C Bode; R Becker; J Anderson; M E Bertrand; C R Conti
Journal:  Clin Cardiol       Date:  1998-05       Impact factor: 2.882

8.  Management and outcomes of lower risk patients presenting with acute coronary syndromes in a multinational observational registry.

Authors:  G Devlin; F A Anderson; S Heald; J López-Sendón; A Avezum; J Elliott; O H Dabbous; D Brieger
Journal:  Heart       Date:  2005-03-10       Impact factor: 5.994

Review 9.  Visceral chest pain in unstable angina pectoris and effects of transcutaneous electrical nerve stimulation. (TENS). A review.

Authors:  M Börjesson
Journal:  Herz       Date:  1999-04       Impact factor: 1.443

10.  ROMEO: a rapid rule out strategy for low risk chest pain. Does it work in a UK emergency department?

Authors:  C Taylor; A Forrest-Hay; S Meek
Journal:  Emerg Med J       Date:  2002-09       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.